A carregar...

Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects

Background  Recombinant (rec-) coagulation factor VIII concentrates available for hemophilia A (HA) treatment differ in cell line production and structure, which could affect their pharmacodynamics and immunogenicity. Clinical trials showed that previously untreated patients with severe HA present h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:TH Open
Main Authors: De Cristofaro, Raimondo, Sacco, Monica, Lancellotti, Stefano, Berruti, Federico, Garagiola, Isabella, Valsecchi, Carla, Basso, Maria, Di Stasio, Enrico, Peyvandi, Flora
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524925/
https://ncbi.nlm.nih.gov/pubmed/31249992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1688413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!